Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Indaptus Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
05/11/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update"
03/17/2023 8-K Quarterly results
Docs: "Indaptus Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update"
08/08/2022 8-K Quarterly results
Docs: "Unaudited Condensed Consolidated Balance Sheets June 30, 2022 December 31, 2021 Assets Current assets: Cash and cash equivalents $ 14,258,812 $ 39,132,165 Marketable securities 18,753,081 - Assets held for sale - 148,400 Prepaid expenses and other current assets 260,884 1,106,653 Total current assets 33,272,777 40,387,218 Non-current assets: Property and equipment, net 2,732 3,800 Right-of-use asset 124,853 169,088 Other assets 659,049 16,477 Total non-current assets 786,634 189,365 Total assets $ 34,059,411 $ 40,576,583 Liabilities and stockholders’ equity Current liabilities: Accounts payable and other current liabilities $ 3,526,034 $ 4,507,676 Operating lease liability, current portion 97,905 96,465 Total current liabilities 3,623,939 4,604,141 Non-current liabilities: Operating lease ..."
05/12/2022 8-K Quarterly results
11/15/2021 8-K Quarterly results
Docs: "Unaudited Condensed Consolidated Balance Sheets September 30, 2021 December 31, 2020 Assets Current assets Cash and cash equivalents $ 41,857,222 $ 1,637,499 Assets held for sale 600,000 - Prepaid expenses and other current assets 1,397,669 94,500 Total current assets 43,854,891 1,731,999 Non-current assets Property and equipment, net 4,335 1,349 Other assets - 44,445 Total non-current assets 4,335 45,794 Total assets $ 43,859,226 $ 1,777,793 Liabilities and stockholders’ equity Current liabilities Accounts payable and other current liabilities $ 5,780,184 $ 598,365 SAFE agreements - 1,417,129 Total current liabilities 5,780,184 2,015,494 Commitments and contingent liabilities Stockholders’ equity Preferred stock; Series Seed; $0.01 par value; 5,000,000 and 972,335 shares authorized as of ..."

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy